Carmen Breslin

Carmen Breslin is an experienced regulatory affairs professional with a strong background in leadership roles across various pharmaceutical companies. Currently serving as Executive Director at ORIC Pharmaceuticals Inc. since April 2019, Carmen previously held positions as Senior Director of Regulatory Operations and Quality. Prior to this, Carmen worked as an Independent Consultant from August 2018 to April 2019 and held multiple roles at IGNYTA, Inc. from June 2015 to July 2018, including Director of Regulatory Operations and Publishing. Carmen also contributed to Seragon Pharmaceuticals, Inc. and Aragon Pharmaceuticals, Inc. as a Senior Manager in Regulatory Affairs and held the position of Regulatory Affairs Manager at Synteract, Inc. from February 2002 to August 2012.